Partial maxillectomy for ameloblastoma of the maxilla with infratemporal fossa involvement: A combined endoscopic endonasal and transoral approach

Guha, Anasuya; Hart, Libor; Polachova, Helena; Chovanec, Martin; Schalek, Petr

doi:10.1016/j.jormas.2018.02.007

Cited by 5 publications

(4 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Radical surgery represents current standard treatment option for ameloblastomas and this will depend on the histological subtype, and surgical technique to be performed in order to obtain surgical margins free of neoplasia, which could reduce local recurrences [16] , [17] .…”

Section: Discussionmentioning

confidence: 99%

Asymptomatic ameloblastoma of the maxilla with infratemporal fossa involvement: A case report

Chebil

Hasnaoui

Bhar

et al. 2022

International Journal of Surgery Case Reports

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Asymptomatic ameloblastoma of the maxilla with infratemporal fossa involvement: A case report

Chebil

Hasnaoui

Bhar

et al. 2022

International Journal of Surgery Case Reports

View full text Add to dashboard Cite

“…16,17 Some surgeons proposed an endoscopic transoral approach, which involved removing the maxillary molar and moving a small part of the lateral maxilla, followed by dissection of the pterygopalatine fossa and the ITF lesion. 18 These approaches all go through the maxillary sinus and pterygopalatine fossa. 11 Extending the incision posterolateral to the medial and the lateral pterygoid muscles is often not required for benign lesions since this leads to more injury after the loss of bones and muscles.…”

Section: Discussionmentioning

confidence: 99%

Endoscopic Trans-Lateral Molar Approach to Infratemporal Fossa Lesions

Wang

et al. 2020

Ear Nose Throat J

View full text Add to dashboard Cite

Background: To study the endoscopic trans-lateral molar (ETLM) approach to infratemporal fossa (ITF) lesions and analyze the advantages and disadvantages of this method. Methods: Four cases of ITF lesions were analyzed retrospectively. The clinical features, diagnosis and treatments, the operative process, and clinical applications of this surgical approach were discussed. Results: Postoperative pathologies were 2 pleomorphic adenomas, 1 schwannoma, and 1 inflammatory lesion. All patients had self-resolving cheek swelling and pharyngalgia in the short term, but 2 patients had numbness in the long term. There was no infection or bleeding in the postoperative period, and no difficulty in chewing after disease recovery. There was no tumor recurrence during the follow-up period. Conclusion: The ETLM approach is convenient, minimally invasive, and allows complete excision of benign ITF lesions, posterior to the lateral pterygoid muscle and mainly below the level of the hard palate. It is a simple and direct access to the ITF, but it is a narrow access because of the limitations of bones and soft tissues. Appropriate patient selection is mandatory for successful surgery.

show abstract

“…As formas de tratamento para os ameloblastomas são amplamente debatidas na literatura, no entanto ainda não há protocolo que se aplique a todos os casos e cada situação deve ser individualizada 6,7 . Critérios como a extensão e os limites do tumor, correlações anatômicas, variante histológica, idade e estado geral do paciente devem ser considerados para se escolher a melhor abordagem 11,12 .…”

Section: Discussionunclassified

“…A proximidade da maxila com o assoalho da órbita, fossa infratemporal e uma série de vasos e nervos nobres, faz com que os ameloblastomas na maxila sejam especialmente perigosos e potencialmente letais, pois possuem maior potencial de complicações e dificuldade de obtenção de margem cirúrgica adequada. Dessa forma, a escolha de uma abordagem que forneça bom acesso e visibilidade é essencial para o sucesso do tratamento 11,12,14,15 .…”

Section: Discussionunclassified

Ameloblastoma em maxila: sugestão de abordagem cirúrgica

Suassuna¹,

Araújo-Júnior²,

Lyra³

et al. 2019

Arch Health Invest

View full text Add to dashboard Cite

Introdução: O ameloblastoma é um tumor benigno, localmente invasivo, originário do epitélio odontogênico e é a neoplasia odontogênica mais comum. Apresentam crescimento lento e sua ocorrência na maxila é pouco frequente. Objetivo: Discutir os métodos de tratamento para os ameloblastomas em maxila e demonstrar a utilidade da osteotomia Le Fort I na abordagem destas lesões. Material e Método: Estudo descritivo de relato de caso. Resultados: Observou-se a erradicação da lesão com uma abordagem de baixa morbidade e que permitiu bom resultado estético e funcional. Conclusão: A ressecção é o método mais indicado para tratamento dos ameloblastomas sólidos, e a sua realização utilizando a osteotomia Le Fort I podem trazer vantagens tanto no trans quanto no pós-operatório.Descritores: Ameloblastoma; Maxila; Osteotomia de Le Fort.ReferênciasKreppel M, Zöller J. Ameloblastoma - Clinical, radiological, and therapeutic findings. Oral Dis. 2018;24(1-2):63-6.Taylor EM, Wu W, Kamali W, Ferraro P, Upton N, Lin J et al. Medial femoral condyle flap reconstruction of a maxillary defect with a 3D printing template. J Reconstr Microsurg Open. 2017;2:e63-8.Menezes LM, Souza CEL, Carneiro JT, Silva Kataoka MS, Júnior SDMA, Pinheiro, JDJV. Maxillary ameloblastoma in an elderly patient: report of a surgical approach. Hum Pathol. 2017;10:25-9.Laborde A, Nicot R, Wojcik T, Ferri J, Raoul G. Ameloblastoma of the jaws: Management and recurrence rate. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(1):7-11. Milman T, Ying GS, Pan W, LiVolsi V. Ameloblastoma: 25 year experience at a single institution. Head Neck Pathol. 2016;10(4):513-20.Pogrel MA, Montes DM. Is there a role for enucleation in the management of ameloblastoma? Int J Oral Maxillofac Surg. 2009;38(8):807-12.Antonoglou GN, Sándor GK. Recurrence rates of intraosseous ameloblastomas of the jaws: a systematic review of conservative versus aggressive treatment approaches and meta-analysis of non-randomized studies. J Craniomaxillofac Surg. 2015;43(1):149-57.Almeida RA, Andrade ES, Barbalho JC, Vajgel A, Vasconcelos BC. Recurrence rate following treatment for primary multicystic ameloblastoma: systematic review and meta-analysis. Int J Oral Maxillofac Surg. 2016;45(3):359-67.Rizzitelli A, Smoll N, Chae M, Rozen WM, Hunter-Smith DJ. Incidence and overall survival of malignant ameloblastoma. PLoS One. 2015;10(2):e0117789.Nastri AL, Wiesenfeld D, Radden BG, Eveson J, Scully C. Maxillary ameloblastoma: a retrospective study of 13 cases. Br J Oral Maxillofac Surg. 1995;33(1):28-32.Guha A, Hart L, Polachova H, Chovanec M, Schalek P. Partial maxillectomy for ameloblastoma of the maxilla with infratemporal fossa involvement: A combined endoscopic endonasal and transoral approach. J Stomatol Oral Maxillofac Surg. 2018;119(3):212-15.Quick-Weller J, Koch F, Dinc N, Lescher S, Baumgarten P, Harter P et al. Intracranial ameloblastoma arising from the maxilla: an interdisciplinary surgical approach. J Neurol Surg A Cent Eur Neurosurg. 2017;78(5):582-87.Abtahi MA, Zandi A, Razmjoo H, Ghaffari S, Abtahi SM, Jahanbani-Arkadani H et al. Orbital invasion of ameloblastoma: a systematic review apropos of a rare entity. J Curr Ophthalmol. 2018;30(1):23-34.Bettoni J, Neiva C, Fanous A, Olivetto M, Demarteleire S, Demarteleire C et al. Brain ameloblastoma: metastasis or local extension report of a case and literature review. J Stomatol Oral Maxillofac Surg. 2018;119(5):436-39.Yang R, Liu Z, Peng C, Cao W, Ji T. Maxillary ameloblastoma: factors associated with risk of recurrence. Head Neck. 2017;39(5):996-1000.Kamalpathey LCK, Sahoo MGNK, Chattopadhyay CPK, Issar MY. Access Osteotomy in the Maxillofacial Skeleton. Ann Maxillofac Surg. 2017;7(1):98-103.Alexander R, Weber WD, Theodos LV, Friedman JS. The treatment of large benign maxillary tumors via Le Fort I downfracture: report of two cases and review of the literature. J Oral Maxillofac Surg. 1992;50(5):515-7.Catunda IS, Melo AR, Medeiros Júnior R, Queiroz IV, Neto F, Leão JC. Osteotomia Le Fort I: Aspectos de interesse no tratamento de nasoangiofibroma juvenil. Rev cir traumatol buco-maxilo-fac. 2011;11(4):9-12.Symington OG, Caminiti MF. Le Fort 1 down fracture approach for the treatment of a posterior maxillary ameloblastoma. J Can Dent Assoc. 1995;61(12):1048-52.Iwaki LC, Tolentino ES, Lustosa RM, Jacomacci WP, Casaroto AR, Leite PC et al. Le Fort I osteotomy for the removal of a rare unicystic ameloblastoma lesion in the maxillary sinus. Gen Dent. 2016;64(3):16-9.

show abstract

Partial maxillectomy for ameloblastoma of the maxilla with infratemporal fossa involvement: A combined endoscopic endonasal and transoral approach

Cited by 5 publications

References 10 publications

Asymptomatic ameloblastoma of the maxilla with infratemporal fossa involvement: A case report

Asymptomatic ameloblastoma of the maxilla with infratemporal fossa involvement: A case report

Endoscopic Trans-Lateral Molar Approach to Infratemporal Fossa Lesions

Ameloblastoma em maxila: sugestão de abordagem cirúrgica

Contact Info

Product

Resources

About